Agenus: Pay

Agenus paid its 3 named executives $2.6M in total in FY2025 (Dec). CEO Garo H. Armen, Ph.D. was paid $1.4M of that.

Pay$100 in the stock at the end of FY21 → $5
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Garo H. Armen, Ph.D.Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Steven J. O’Day, M.D.Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Christine M. KlaskinVice President, Finance
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 3 peers with pay on file was $2.5M. The CEO of Agenus was paid $1.4M, 46% below the median.

  1. 1Precigen
  2. 2Voyager Therapeutics
  3. 3Fate Therapeutics
  4. 4Agenus
  5. 52seventy bioNot disclosed
  6. 6ALX OncologyNot disclosed
  7. 7Atara Biotherapeutics, Inc.Not disclosed
  8. 8ImmuneeringNot disclosed
  9. 9InhibrxNot disclosed
  10. 10Inovio Pharmaceuticals, Inc.Not disclosed
  11. 11Instil BioNot disclosed
  12. 12Karyopharm Therapeutics Inc.Not disclosed
  13. 13MacroGenics, Inc.Not disclosed
  14. 14Mersana Therapeutics, Inc.Not disclosed
  15. 15Precision BioSciences, Inc.Not disclosed
  16. 16Repare TherapeuticsNot disclosed
  17. 17Seres Therapeutics, Inc.Not disclosed
  18. 18Sutro BiopharmaNot disclosed
  19. 19Zentalis Pharmaceuticals, Inc.Not disclosed
  20. 20iTeos TherapeuticsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.